-
1دورية أكاديمية
المؤلفون: Park, Ji-Eun, Kim, Seong-Eun, Keam, Bhumsuk, Park, Ha-Ram, Kim, Soyeon, Kim, Miso, Kim, Tae Min, Doh, Junsang, Kim, Dong-Wan, Heo, Dae Seog
المساهمون: 도준상, 김동완, 허대석, Doh, Junsang, Kim, Dong-Wan, Heo, Dae Seog
مصطلحات موضوعية: ACQUIRED-RESISTANCE, TUMOR-CELLS, POLYMORPHISMS, MECHANISM, MPDL3280A, THERAPY, CD107A, PD-L1, killer cells, natural, immunotherapy, cytotoxicity, immunological, lung neoplasms, head and neck neoplasms
العلاقة: Journal for ImmunoTherapy of Cancer, Vol.8 No.2, p. e000873; 113243; https://hdl.handle.net/10371/171814Test; 000573896000003; 2-s2.0-85089794266
-
2دورية أكاديمية
المؤلفون: Tsai, Katy K, Zarzoso, Inés, Daud, Adil I
المصدر: Human Vaccines & Immunotherapeutics, vol 10, iss 11
مصطلحات موضوعية: Cancer, Immunization, Climate-Related Exposures and Conditions, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, B7-H1 Antigen, CTLA-4 Antigen, Humans, Immunotherapy, Lymphocyte Activation, Melanoma, Nivolumab, Programmed Cell Death 1 Receptor, T-Lymphocytes, BMS-936559, PD-1, PD-L1, PD-L2, MPDL3280A, pembrolizumab, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4
الوقت: 3111 - 3116
وصف الملف: application/pdf
العلاقة: qt49q8w2dj; https://escholarship.org/uc/item/49q8w2djTest
-
3
المؤلفون: Roche
مصطلحات موضوعية: Conditions Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer, Interventions Atezolizumab MPDL3280A [TECENTRIQ], an engineered anti-PDL1 antibody, Interventions Carboplatin, Interventions Cisplatin, Interventions Gemcitabine, Interventions Pemetrexed